GPT and metabolic dysfunction-associated steatotic liver disease: A similar RCT by Chen et al. with 60 NAFLD patients randomized to either placebo or 600 mg of resveratrol for three months noted improved levels of ALT, AST, insulin resistance, and inflammatory factors [28].